FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 90 filers reported holding FATE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $422,330 | -36.0% | 128,759 | -27.0% | 0.00% | 0.0% |
| Q4 2023 | $660,091 | +13.3% | 176,495 | -35.8% | 0.00% | 0.0% |
| Q3 2023 | $582,578 | +90.6% | 274,801 | +327.9% | 0.00% | 0.0% |
| Q2 2023 | $305,682 | -56.8% | 64,219 | -48.3% | 0.00% | -66.7% |
| Q1 2023 | $708,048 | -88.2% | 124,219 | -79.1% | 0.00% | -87.5% |
| Q4 2022 | $6,005,921 | +1736.7% | 595,235 | +4407.0% | 0.02% | +1100.0% |
| Q2 2022 | $327,000 | -78.3% | 13,207 | -48.7% | 0.00% | -50.0% |
| Q4 2021 | $1,506,000 | -74.0% | 25,739 | -73.7% | 0.00% | -76.5% |
| Q3 2021 | $5,801,000 | +935.9% | 97,874 | +1415.5% | 0.02% | +750.0% |
| Q2 2021 | $560,000 | -55.5% | 6,458 | -57.7% | 0.00% | -71.4% |
| Q1 2021 | $1,259,000 | +150.8% | 15,269 | +21.6% | 0.01% | 0.0% |
| Q3 2020 | $502,000 | -78.0% | 12,553 | -81.1% | 0.01% | -81.1% |
| Q2 2020 | $2,284,000 | +656.3% | 66,579 | +389.6% | 0.04% | +362.5% |
| Q1 2020 | $302,000 | -75.9% | 13,600 | -78.7% | 0.01% | +14.3% |
| Q4 2019 | $1,251,000 | -51.9% | 63,901 | -61.8% | 0.01% | -69.6% |
| Q3 2019 | $2,600,000 | +274.1% | 167,411 | +388.7% | 0.02% | +228.6% |
| Q2 2019 | $695,000 | -52.8% | 34,258 | -59.1% | 0.01% | -56.2% |
| Q1 2019 | $1,472,000 | +481.8% | 83,773 | +325.4% | 0.02% | +433.3% |
| Q4 2018 | $253,000 | -72.0% | 19,695 | -64.5% | 0.00% | -72.7% |
| Q3 2018 | $905,000 | +1192.9% | 55,532 | +387.3% | 0.01% | +1000.0% |
| Q4 2017 | $70,000 | -25.5% | 11,397 | -60.6% | 0.00% | -50.0% |
| Q2 2017 | $94,000 | -28.2% | 28,900 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $131,000 | +162.0% | 28,900 | +44.5% | 0.00% | +100.0% |
| Q4 2016 | $50,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
| Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
| Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
| Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
| DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
| Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
| Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
| Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
| Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |